Last updated on August 2020

A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH


Brief description of study

The study includes 52 weeks, double-blind treatment period. Clinic visits will occur at Randomization and every four weeks from Week 4 through Week 52 and through End of Study period. The study includes a post-dosing study visit that will occur 4 weeks after the last dose of study drug. This visit represents the End-of-Study Visit (Week 56 Visit). Three hundred thirty-seven subjects will be enrolled into five treatment arms and there will be an equal distribution of males and females in each treatment arm. Subjects will be stratified by gender, fibrosis stage, and diabetes status.

Clinical Study Identifier: NCT04173065

Find a site near you

Start Over

Viking Clinical Site 105

Madison, AL United States
  Connect »

Viking Clinical Site 130

South Bend, IN United States
  Connect »

Viking Clinical Site 126

Concord, NC United States
  Connect »

Viking Clinical Site 101

San Antonio, TX United States
  Connect »

Viking Clinical Site 201

San Antonio, TX United States
  Connect »

Viking Clinical Site 206

Birmingham, AL United States
  Connect »

Viking Clinical Site 212

Chandler, AZ United States
  Connect »

Viking Clinical Site 208

Fresno, CA United States
  Connect »

Viking Clinical Site 204

Los Angeles, CA United States
  Connect »

Viking Clinical Site 25

Panorama City, CA United States
  Connect »

Viking Clinical Site 110

Rialto, CA United States
  Connect »

Viking Clinical Site 202

Englewood, CO United States
  Connect »

Viking Clinical Site 106

Miami, FL United States
  Connect »

Viking Clinical Site 131

Pensacola, FL United States
  Connect »

Viking Clinical Site 111

Marietta, GA United States
  Connect »

Viking Clinical Site 211

West Des Moines, IA United States
  Connect »

Viking Clinical Site 107

Greenbelt, MD United States
  Connect »

Viking Clinical Site 118

Hermitage, TN United States
  Connect »

Viking Clinical Site 115

Arlington, TX United States
  Connect »

Viking Clinical Site 104

Houston, TX United States
  Connect »

Viking Clinical Site 102

San Antonio, TX United States
  Connect »

Viking Clinical Site 216

Glendale, AZ United States
  Connect »

Viking Clinical Site 205

Panorama City, CA United States
  Connect »

Viking Clinical Site 125

Pasadena, CA United States
  Connect »

Viking Clinical Site 215

Port Orange, FL United States
  Connect »

Viking Clinical Site 139

Zephyrhills, FL United States
  Connect »

Viking Clinical Site 109

Baltimore, MD United States
  Connect »

Viking Clinical Site 143

San Antonio, TX United States
  Connect »

Viking Clinical Site 214

North Little Rock, AR United States
  Connect »

Viking Clinical Site 134

Montclair, CA United States
  Connect »

Viking Clinical Site 217

Kansas City, MO United States
  Connect »

Viking Clinical Site 137

Cincinnati, OH United States
  Connect »

Viking Clinical Site 127

Greenville, SC United States
  Connect »

Viking Clinical Site 103

San Francisco, CA United States
  Connect »

Viking Clinical Site 301

Miami, FL United States
  Connect »

Viking Clinical Site 218

Sarasota, FL United States
  Connect »

Viking Clinical Site 144

Atlanta, GA United States
  Connect »

Viking Clinical Site 213

Jackson, MS United States
  Connect »

Viking Clinical Site 311

Pittsburgh, PA United States
  Connect »

Viking Clinical Site 129

Chicago, IL United States
  Connect »

Viking Clinical Site 209

Richmond, VA United States
  Connect »

Viking Clinical Site 120

Indianapolis, IN United States
  Connect »

Viking Clinical Site 141

Charlotte, NC United States
  Connect »

Viking Clinical Site 108

Cleveland, OH United States
  Connect »

Viking Clinical Site 128

Rochester, NY United States
  Connect »

Viking Clinical Site 113

Dallas, TX United States
  Connect »

Viking Clinical Site 306

Atlanta, GA United States
  Connect »

Viking Clinical Site 133

Detroit, MI United States
  Connect »

Viking Clinical Site 304

Newport News, VA United States
  Connect »

Viking Clinical Site 145

Topeka, KS United States
  Connect »

Viking Clinical Site 112

Kansas City, MO United States
  Connect »

Viking Clinical Site 316

San Francisco, CA United States
  Connect »

Viking Clinical Site 146

Marrero, LA United States
  Connect »

Viking Clinical Site 310

Miami, FL United States
  Connect »

Viking Clinical Site 313

Philadelphia, PA United States
  Connect »

Viking Clinical Site 142

Houston, TX United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.